Nearly a quarter of a million Americans each year may be hospitalized with bleeding complications caused by needlessly taking a daily dose of an adult-sized aspirin rather than a baby aspirin to prevent a heart attack or stroke.
Data released today show that MR-guided focused ultrasound (MRgFUS) is a more effective option for a broader population of uterine fibroid sufferers.
A written constitution for the NHS, overseen by an independent Board of Governors are two of the major recommendations published today by the British Medical Association (BMA) in its proposals for the future of the NHS in England.
GlaxoSmithKline [GSK: NYSE] commended the commitment of the World Health Organization (WHO) to progress plans for ensuring that the world?s most vulnerable people are protected in the event of a pandemic. Key elements of that commitment include progress being made towards the development of an H5N1 vaccine global stockpile by the WHO, and efforts to establish an additional mechanism to ensure broader access to pandemic influenza vaccine for developing world countries.
Bayer HealthCare Pharmaceuticals Inc, a U.S.-based pharmaceuticals unit of Bayer HealthCare., and Intendis Inc., a U.S.-based affiliate of Bayer Schering Pharma AG, Germany, announced today that they will jointly promote YAZ? (drospirenone/ethinyl estradiol) as a treatment for moderate acne in women who desire an oral contraceptive for birth control. The agreement came into effect on May 1, as part of an overall strategy to introduce dermatologists to the anti-acne benefits of YAZ.
Bayer HealthCare Pharmaceuticals announced the results of three clinical studies with Betaseron? (interferon beta-1b), presented this week at the American Academy of Neurology’s (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction with treatment in patients with relapsing forms of multiple sclerosis (MS).
Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), announced that the Company has received two U.S. Food and Drug Administration (FDA) approvals related to its ENJUVIA(TM) (synthetic conjugated estrogens, B) product.
Today, nearly 40 of the US’s top business leaders and largest employers joined forces to announce the formation of the Coalition to Advance Healthcare Reform (CAHR). Standing shoulder to shoulder with lawmakers at a Capitol Hill press conference, they discussed the coalition’s core principles, its mission and called for meaningful federal and state policy reforms by 2009 to solve the nation’s healthcare crisis.
The American Nurses Association (ANA) recommends the assignment and daily availability of school nurses in educational settings to address the safety and health care needs of the nation’s children. Students’ health and health needs must be addressed in schools to achieve optimum learning, and registered nurses, at a ratio of one for every 750 students, are essential in promoting health, preventing injury, and providing direct health care services to school students to achieve a safe and healthy learning environment.
The Centers for Disease Control and Prevention (CDC) part of the Department of Health and Human Services (HHS) today released interim advice to the public about the use of facemasks and respirators in certain public (non-occupational) settings during an influenza pandemic. There is very little research about the value of masks to protect people in public settings. These interim recommendations are based on the best judgment of public health experts who relied in part on information about the protective value of masks in healthcare facilities.